Lilly and Incyte Provide Update on Baricitinib
Go back to Lilly and Incyte Provide Update on Baricitinib| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 123.89 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $123.89 | 52 Week High | $118.49 | |||
| Open | $123.89 | 52 Week Low | $55.00 | |||
| Day High | $123.89 | P/E | N/A | |||
| Day Low | $123.89 | EPS | $-0.56 | |||
| Volume | 80 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1183.46 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1183.46 | 52 Week High | $88.16 | |||
| Open | $1183.46 | 52 Week Low | $67.88 | |||
| Day High | $1183.46 | P/E | 273.95 | |||
| Day Low | $1183.46 | EPS | $4.32 | |||
| Volume | 3,075 | |||||

